Innate Pharma to present IPH4102 “TELLOMAK” clinical trial design and preclinical PTCL data at the 2019 ICML
Source:
Nasdaq GlobeNewswire
/
12 Jun 2019 01:00:12 America/Los_Angeles
N/A
Share on,